Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | PDCD1 | Q15116 | 2/20 | 0.41 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.40 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.38 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.38 |
| ▸ | CYP3A7 | P24462 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CYP3A43 | Q9HB55 | 1/20 | 0.38 |
| ▸ | CYP46A1 | Q9Y6A2 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyproconazole SCHEMBL13014891 | 1.00 | KMT2A (0.53) | KMT2ACYP3A4ALDH1A1HSP90AA1PDCD1 | |
| Cyproconazole SCHEMBL20791 | 1.00 | KMT2A (0.53) | KMT2ACYP3A4ALDH1A1HSP90AA1PDCD1 | |
| Cyproconazole SCHEMBL28950859 | 1.00 | KMT2A (0.53) | KMT2ACYP3A4ALDH1A1HSP90AA1PDCD1 | |
| Cyproconazole SCHEMBL23532643 | 0.99 | KMT2A (0.52) | KMT2ACYP3A4ALDH1A1HSP90AA1PDCD1 | |
| Cyproconazole SCHEMBL28839157 | 0.99 | KMT2A (0.52) | KMT2ACYP3A4ALDH1A1HSP90AA1PDCD1 | |
| Cyproconazole SCHEMBL28396979 | 0.99 | KMT2A (0.52) | KMT2ACYP3A4ALDH1A1HSP90AA1PDCD1 | |
| Cyproconazole SCHEMBL12475814 | 0.89 | KMT2A (0.43) | KMT2ACYP3A4ALDH1A1HSP90AA1PDCD1 | |
| Cyproconazole SCHEMBL8463921 | 0.89 | KMT2A (0.43) | KMT2ACYP3A4ALDH1A1HSP90AA1PDCD1 | |
| Cyproconazole SCHEMBL8164442 | 0.87 | KMT2A (0.42) | KMT2ACYP3A4ALDH1A1HSP90AA1PDCD1 | |
| Cyproconazole SCHEMBL2555661 | 0.87 | KMT2A (0.42) | KMT2ACYP3A4ALDH1A1HSP90AA1PDCD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100305161-A1 | COMBINATIONS OF FUNGICIDAL AZOLES AND PYRION COMPOUNDS | BOSSELAERS JAN PETER HENDRIK | 2010-12-02 | — | — | US | disclosed |
| CN-101877968-A | Fungicidal azole compounds and pyrion combination of compounds | JANSSEN PHARMACEUTICA NV | 2010-11-03 | — | — | CN | disclosed |
| US-7662748-B2 | Such as azaconazole, bromuconazole, and N,N',N'-tris(2-hydroxyethyl)-N-cocoalkyl-1,3-diamino-propane; kits; for protection of crops, plants, fruits, seeds, wood products, thatch, biodegradable material and textiles | JANSSEN PHARMACEUTICA, N.V. (BE) | 2010-02-16 | — | — | US | disclosed |
| CN-100399897-C | Formulations containing triazoles and alkoxylated amines | JANSSEN PHARMACEUTICA NV (BE) | 2008-07-09 | — | — | CN | disclosed |
| CN-1627900-A | Formulations comprising triazoles and alkoxylated amines | JANSSEN PHARMACEUTICA NV (BE) | 2005-06-15 | — | — | CN | disclosed |
| US-20050080089-A1 | Formulations comprising triazoles and alkoxylated amines | AKZO NOBEL CHEMICALS BV (NL) | 2005-04-14 | — | — | US | disclosed |
| US-5714507-A | FUNGICIDE | JANSSEN PHARMACEUTICA, N.V. (BE) | 1998-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080089-A1 | Formulations comprising triazoles and alkoxylated amines | ALKBH3, TYR, NAT1 | KMT2A 1163/4885CYP3A4 100/4885ALDH1A1 469/4885 |
| US-20100305161-A1 | COMBINATIONS OF FUNGICIDAL AZOLES AND PYRION COMPOUNDS | PPOX, PNPO, CYP3A43 | KMT2A 4343/4885CYP3A4 7/4885ALDH1A1 1720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.